Hope for untreatable chest pain? new drug trial launches
Symptom relief
Terminated
This study aimed to test a new drug called IMB-1018972 for people with severe, persistent chest pain (refractory angina) that doesn't respond well to standard medications. It planned to see if the drug was safe and if it could help patients exercise longer and have fewer chest pa…
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC